Detailed Information on Publication Record
2014
Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH
KUGLÍK, Petr, Jan SMETANA, Vladimíra VALLOVÁ, Lucie MOUKOVÁ, Kateřina KAŠÍKOVÁ et. al.Basic information
Original name
Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH
Authors
KUGLÍK, Petr (203 Czech Republic, guarantor, belonging to the institution), Jan SMETANA (203 Czech Republic, belonging to the institution), Vladimíra VALLOVÁ (703 Slovakia, belonging to the institution), Lucie MOUKOVÁ (203 Czech Republic), Kateřina KAŠÍKOVÁ (203 Czech Republic, belonging to the institution), Michaela CVANOVÁ (203 Czech Republic, belonging to the institution) and Lucie BROŽOVÁ (203 Czech Republic, belonging to the institution)
Edition
International Journal of Clinical and Experimental Pathology, USA, e-Century Publishing Corporation, Madiso, 2014, 1936-2625
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
Genetics and molecular biology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.891
RIV identification code
RIV/00216224:14310/14:00078290
Organization unit
Faculty of Science
UT WoS
000345120900052
Keywords in English
Cervical carcinoma; whole-genome profiling; CGH+SNP microarrays; HPV-FISH; copy number alterations
Tags
International impact, Reviewed
Změněno: 28/4/2015 09:32, Ing. Andrea Mikešková
Abstract
V originále
Alterations in the genome that lead to changes in DNA sequence copy number are characteristic features of solid tumors. We used CGH+SNP microarray and HPV-FISH techniques for detailed screening of copy number alterations (CNAs) in a cohort of 26 patients with cervical carcinoma (CC). This approach identified CNAs in 96.2% (25/26) of tumors. Array-CGH discovered CNAs in 73.1% (19/26) of samples, HPV-FISH experiments revealed CNAs in additional 23.1% (6/26) of samples. Common gains of genetic sequences were observed in 3q (50.0%), 1q (42.4%), 19q (23.1%), while losses were frequently found in 11q (30.8%), 4q (23.1%) and 13q (19.2%). Chromosomal regions involved in loss of heterozygosity were observed in 15.4% of samples in 8q21, 11q23, 14q21 and 18q12.2. Incidence of gain 3q was associated with HPV 16 and HPV 18 positive samples and simultaneous presence of gain 1q (P = 0.033). We did not found a correlation between incidence of CNAs identified by array-CGH and HPV strain infection and incidence of lymph node metastases. Subsequently, HPV-FISH was used for validation of array-CGH results in 23 patients for incidence of hTERC (3q26) and MYC (8q24) amplification. Using HPV-FISH, we found chromosomal lesions of hTERC in 87.0% and MYC in 65.2% of specimens. Our findings confirmed the important role of HPV infection and specific genomic alterations in the development of invasive cervical cancer. This study also indicates that CGH+SNP microarrays allow detecting genome-wide CNAs and copy-neutral loss of heterozygosity more precisely, however, it may be less sensitive than FISH in samples with low level clonal CNAs.
Links
EE2.3.20.0183, research and development project |
| |
NT11089, research and development project |
|